Rondo Therapeutics

Biotech · Private

Engineered cytokine platform for tumor-selective immune activation

rondotx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3218Shield Pharma LLC——
3219QWIXEL THERAPEUTICS, LLC——
3220TARGAZYME, INC.——
3221Rondo Therapeutics——
3222GROW BIOMEDICINE LLC——
3223VELUM INC——
3224Proneurogen, Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Bispecific Antibodies That Bind To CD28 And NECTIN-4application
  • Bispecific Antibodies That Bind To CD28 And NECTIN-4application
  • Bispecific Antibodies That Bind To CD28 And NECTIN-4application

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.